{"grounding": "Normal tissues progressively acquire mutations. Some mutations are positively selected, driving clonal expansions that may colonize the majority of a tissue by old age. In several cases mutant clonal expansion is due to biasing stem cell fate toward proliferation. However, the expansionary phase is transient and is followed by reversion toward wild-type behavior so that normal tissue integrity is retained. Here we consider the implications of these findings for carcinogenesis. We propose that to be considered a cancer driver, a mutant gene should be more prevalent in tumors than the normal lineage from which it emerged. Cancer risk is not dependent on mutational burden, but rather may reflect the relative frequency of pro- and anti-oncogenic mutants within a tissue. Understanding the basis of mutant clonal advantage over wild-type cells allows interventions to halt the expansion or even deplete oncogenic mutants from normal tissue, potentially lowering cancer risk.", "generated_text": "Recent advances in genomic technologies have unveiled the prevalence of somatic mutations in normal tissues, offering novel insights into early carcinogenesis. This study explores the accumulation of mutations in stem cells as a function of aging and exposure to environmental carcinogens. By analyzing mutation patterns across various tissue types, we identify key mutational signatures that precede malignant transformation. Our findings suggest that the mutational burden in normal tissues increases with age, potentially serving as a reservoir for oncogenic mutations. Furthermore, the role of stem cells in maintaining tissue homeostasis is highlighted, as they are both targets and propagators of these mutations. Understanding the dynamics of somatic mutations in normal tissues could revolutionize cancer prevention strategies, emphasizing early detection and intervention. This research underscores the importance of integrating genomic surveillance in routine health assessments to mitigate the risk of cancer development, thereby enhancing public health outcomes.", "label": 1}